Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$411K Buy
4,049
+1,449
+56% +$156K 0.16% 149
2023
Q2
$274K Buy
2,600
+361
+16% +$41K 0.1% 199
2023
Q1
$259K Buy
+2,239
New +$242K 0.1% 198
2021
Q3
Sell
-4,953
Closed -$386K 231
2021
Q2
$386K Buy
4,953
+396
+9% +$29.5K 0.08% 208
2021
Q1
$320K Sell
4,557
-5,122
-53% -$378K 0.09% 194
2020
Q4
$712K Buy
9,679
+1,223
+14% +$93.5K 0.22% 110
2020
Q3
$646K Buy
+8,456
New +$662K 0.26% 92

Other funds holding MRK

TRUADVICE's MRK Position: Q3 2023 in Review

TRUADVICE increased its Merck (MRK) stake by 56% in Q3 2023, buying an estimated $156K and bringing the position to 4,049 shares worth $411K. The position accounts for 0.16% of the portfolio, ranked #149.

TRUADVICE first reported a position in MRK in Q3 2020 and has held it in 7 quarters since. The position peaked at $712K in Q4 2020. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • TRUADVICE held 4,049 shares of Merck worth $411K as of Q3 2023.
  • TRUADVICE bought 1,449 Merck shares in Q3 2023, an estimated $156K.
  • Merck made up 0.16% of TRUADVICE's portfolio in Q3 2023, its #149 holding.
  • TRUADVICE first reported a position in Merck in Q3 2020 and has held it in 7 quarters since.
  • TRUADVICE's Merck position peaked at $712K in Q4 2020.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.